Jin Zhi Xiang - Net Worth and Insider Trading

Jin Zhi Xiang Net Worth

The estimated net worth of Jin Zhi Xiang is at least $2 Million dollars as of 2024-06-22. Jin Zhi Xiang is the Supervisors of Shanxi Zhendong Pharmaceutical Co Ltd and owns about 385,900 shares of Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) stock worth over $2 Million. Details can be seen in Jin Zhi Xiang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jin Zhi Xiang has not made any transactions after 2016-11-24 and currently still holds the listed stock(s).

Transaction Summary of Jin Zhi Xiang

To

Jin Zhi Xiang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jin Zhi Xiang owns 1 companies in total, including Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) .

Click here to see the complete history of Jin Zhi Xiang’s form 4 insider trades.

Insider Ownership Summary of Jin Zhi Xiang

Ticker Comapny Transaction Date Type of Owner
SZSE:300158 Shanxi Zhendong Pharmaceutical Co Ltd 2016-11-24 Supervisors

Jin Zhi Xiang Latest Holdings Summary

Jin Zhi Xiang currently owns a total of 1 stock. Jin Zhi Xiang owns 385,900 shares of Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) as of November 24, 2016, with a value of $2 Million.

Latest Holdings of Jin Zhi Xiang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300158 Shanxi Zhendong Pharmaceutical Co Ltd 2016-11-24 385,900 3.92 1,512,728

Holding Weightings of Jin Zhi Xiang


Jin Zhi Xiang Form 4 Trading Tracker

According to the SEC Form 4 filings, Jin Zhi Xiang has made a total of 0 transactions in Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) over the past 5 years. The most-recent trade in Shanxi Zhendong Pharmaceutical Co Ltd is the sale of 22,799 shares on November 24, 2016, which brought Jin Zhi Xiang around $515,257.

Insider Trading History of Jin Zhi Xiang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jin Zhi Xiang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jin Zhi Xiang Ownership Network

Ownership Network List of Jin Zhi Xiang

No Data

Ownership Network Relation of Jin Zhi Xiang

Insider Network Chart

Jin Zhi Xiang Owned Company Details

What does Shanxi Zhendong Pharmaceutical Co Ltd do?

Who are the key executives at Shanxi Zhendong Pharmaceutical Co Ltd?

Jin Zhi Xiang is the Supervisors of Shanxi Zhendong Pharmaceutical Co Ltd. Other key executives at Shanxi Zhendong Pharmaceutical Co Ltd include Executives Ma Shi Feng , Executives Li Zhi Xu , and Executives You Rong Li .

Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shanxi Zhendong Pharmaceutical Co Ltd Insider Transactions

No Available Data

Jin Zhi Xiang Mailing Address

Above is the net worth, insider trading, and ownership report for Jin Zhi Xiang. Currently GuruFocus does not have mailing address information for Jin Zhi Xiang.

Discussions on Jin Zhi Xiang

No discussions yet.